Selective Serotonin Reuptake Inhibitors Reduce the Attack Frequency in Familial Mediterranean Fever
- 1 January 2007
- journal article
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 211 (1) , 9-14
Abstract
Familial Mediterranean Fever (FMF) is characterized by recurrent acute attacks of fever and serositis, and colchicine is the primary treatment. The pathogenesis of the disease has not been fully understood. Resistance to colchicine remains to be a problem in up to 30% of the patients and yet there seems to be no alternative treatment. In this study our objective was to investigate whether a selective serotonin re-uptake inhibitor (SSRI) could affect the attack frequency and acute phase response in FMF patients who were unresponsive to colchicine. We retrospectively evaluated the hospital files of 11 colchicine-unresponsive FMF patients who had been treated with SSRIs. According to the records and re-evaluation of the patients, the total number of the FMF attacks was calculated before and after the SSRI, adjunct to colchicine. The laboratory values including erythrocyte sedimentation rate, C-reactive protein, fibrinogen and white blood cell counts were also noted before and after the SSRI treatment from their hospital files. The mean attack frequency before adding SSRI to colchicine was 8.09 +/- 3.53 per 6 months, and at the end of this period there was a great decline in the number of mean attack frequency (0.36 +/- 0.50 attacks per 6 months) (p < 0.001). Acute phase reactants were significantly decreased after SSRI treatment (p < 0.001). All of the colchicine-unresponsive patients had depression and 3 of those patients also had fibromyalgia. SSRIs appear to be useful adjuncts in the management of FMF patients who continue to have attacks despite regular colchicine treatment.Keywords
This publication has 21 references indexed in Scilit:
- Familial Mediterranean fever responds well to infliximab: single case experienceClinical Rheumatology, 2005
- Does inhibition of P-glycoprotein lead to drug–drug interactions?Toxicology Letters, 2005
- Drugs as P-glycoprotein substrates, inhibitors, and inducersDrug Metabolism Reviews, 2002
- Hereditary Periodic FeverNew England Journal of Medicine, 2001
- Interaction between Pyrin and the Apoptotic Speck Protein (ASC) Modulates ASC-induced ApoptosisJournal of Biological Chemistry, 2001
- Anti-Inflammatory Effects of Antidepressants Through Suppression of the Interferon-γ/Interleukin-10 Production RatioJournal of Clinical Psychopharmacology, 2001
- Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramineInternational Journal of Neuropsychopharmacology, 2000
- Serotonin Transporter-Blocking Properties of Nefazodone Assessed by Measurement of Platelet SerotoninJournal of Clinical Psychopharmacology, 1998
- Criteria for the diagnosis of familial mediterranean feverArthritis & Rheumatism, 1997
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990